Minorities underrepresented in clinical trials for breast cancer
Researchers say improving inclusion will require coordinated changes in how studies are designed, explained and made accessible.
Researchers say improving inclusion will require coordinated changes in how studies are designed, explained and made accessible.
Immunotherapy can improve the chance of tumor disappearance before surgery and may extend survival in certain high-risk groups.
Black patients with HR+, HER2 negative metastatic breast cancer were less likely to receive recommended therapy and had shorter survival.
A new DNA-based treatment has shown early promise and works by removing a cancer-driving protein instead of blocking it.
Most BC survivors reported better overall quality of life after their mastectomies, but many continued to experience limitations and strain.